Search For "niaid"
Research: Clinical trials of mRNA global influenza vaccine candidate begin
Updated : 2 years, 10 months ago IST
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Centre (VRC), which is part of the National Institutes of Health, has begun at Duke University in Durham, North Carol
Read More
New study explores challenges of developing mucosal vaccines for respirato
Updated : 3 years, 1 month ago IST
Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) are difficult to develop. In a new review article in Cell Host & Microbe, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the N
Read More
Marburg vaccine shows promising results in first-in-human study
Updated : 3 years, 1 month ago IST
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID),
Read More
Scientists find key to hepatitis C entry into cells, findings provide new
Updated : 4 years, 5 months ago IST
Washington [US], September 22 (ANI): Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe the structure of a key protein on the surface of the hepatitis C virus (HCV) and how it interacts with its receptor foun
Read More
Independent US board expresses concern over AstraZeneca's announcements ab
Updated : 4 years, 11 months ago IST
Washington [US], March 23 (ANI): An independent board that reviews data from multiple Covid-19 vaccine candidates in the United States has expressed concern over AstraZeneca's announcements about its latest findings, according to a statement posted Tuesday by the National Institute of Allerg
Read More
US launches Phase 3 trial of 2 new antibody treatments for COVID-19
Updated : 5 years, 2 months ago IST
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two experimental drugs to treat hospitalized COVID-19 patients when combined with existing treatments, said the National Institute for Allergy and Infectious Diseases (NIAID) (local time
Read More
NIH launches clinical trial in US to test potential therapeutics for mild,
Updated : 5 years, 7 months ago IST
Washington D.C. [US], Aug 5 (Xinhua/ANI): The U.S. National Institutes of Health (NIH) said on Tuesday a Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies
Read More
Hospitalized patients with advanced COVID-19 who received remdesivir recov
Updated : 5 years, 10 months ago IST
Washington D.C. [US], April 30 (ANI): A preliminary data analysis from NIH clinical trial shows that hospitalized patients with "advanced COVID-19 and lung involvement who received the investigational antiviral remdesivir recovered faster than similar patients who received placebo".
Read More
MAHE partners with NIAID TB portals program of NIH, USA
Updated : 7 years, 3 months ago IST
New Delhi [India], Dec 14 (ANI-BusinessWireIndia): Manipal Academy of Higher Education (MAHE) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) to become a member of the NIAID TB Portals program (See: https://tbportals.n
Read More